CymaBay Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/13/2024
Shares
14,924
Value ($000)
353
Weight
0.0%
2022 Q2 - 2023 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).